Radioiodine therapy for papillary and follicular thyroid carcinoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12192549.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Radioiodine ((131)I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease. It should be used selectively, i.e. only in those patients for whom a clinical benefit may be expected.
Medical subject headings
- Adenocarcinoma, Follicular
- Carcinoma, Papillary
- Iodine Radioisotopes
- Radiopharmaceuticals
- Thyroid Neoplasms